Tag: Coronavirus information (COVID-19)
Press Releases
Lonza and Moderna Enter New Agreement to Double Drug Substance Production for COVID-19 Vaccine in Visp
Lonza announced the expansion of its collaboration with Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, to manufacture the drug substance...
Packaging & Labelling
FedEx delivers critical healthcare supplies to India to support the fight against COVID-19
FedEx Express, a subsidiary of FedEx Corp. and one of the world’s largest express transportation companies, is working with organizations around the world to...
News
C4Diagnostics Announces CE Marking of C4Covid-19 HumanTM: a Covid-19 Saliva-Based Rapid Diagnostic Test
C4Diagnostics, a French biotech developing innovative In vitro diagnostic tests for infectious diseases, announced today the CE marking and commercialization of C4Covid-19 HumanTM for...
Clinical Trials
Kintor Pharmaceuticals Announces Successful Proxalutamide COVID-19 Phase III Clinical Trial Initiation and Patient Dosing in U.S.
Kintor Pharmaceutical Limited, a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced that the phase III clinical trial of proxalutamide for...
News
U.S. Resumes Use of Johnson & Johnson COVID Vaccine
The FDA and Centers for Disease Control lifted their recommended pause of the Johnson & Johnson coronavirus vaccine, with no restrictions on who can...
Industry Reports
CPhI post-pandemic executive pharma survey: COVID-19 driving manufacturing and CDMOs driving growth
Ahead of CPhI Discover (17th-28th May, 2021) – global pharma’s largest ever virtual gathering – the CPhI executive post-pandemic pharma survey predicts that pandemic...
Drug Research
Sanofi to invest in a leading-edge production site in Singapore; continues to strengthen its vaccines manufacturing capacities
Sanofi announced a €400 million investment over five years to create a unique vaccine production center in Singapore, pushing the boundaries of operations through...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read